CLV

The CLV unit is involved in WP3 (prospective validation by RCT of the farmacodynamic response by biomarkers) and WP6 (Networking, communication, and exploitation). Activity of this Nephrology Unit focuses on conservative therapy of CKD. Major mission is to delay ESKD by multifactorial therapy, including nutritional intervention and multi-drug approach. Research includes observational and interventional studies, and meta-analyses. The Unit leads several national studies in Nephrology and has been involved in several international trials. In particular, Investigators are recognized worldwide for the studies on the prognostic role of 24h blood pressure control in nondialysis CKD.

People involved in Prime-CKD

Luca De Nicola

Luca De Nicola is Full Professor in Nephrology and Director of Nephrology Unit and Postgraduate School of Nephrology at University of Campania, Naples, Italy, since 2019. His clinical and research activity is mainly dedicated to management of cardiorenal complications in non-dialysis CKD patients. He is author of almost 300 papers published on peer-reviewed internationa journals (H index 47), and he is/has been national leader of several RCTs on nephroprotection in CKD.

Roberto Minutolo

Roberto Minutolo is Associate Professor in Nephrology at University of Campania, Naples, Italy, since 2001. His clinical and research activity is mainly dedicated to management of complications in non-dialysis CKD patients. He is responsible for the outpatient clinic activities at Nephrology Division of University of Campania. He is author of more than 200 papers peer-reviewed published on main nephrology journals (H index 45) and he is/has been Member of the Editorial Boards for several journals.

CLV

People involved in Prime-CKD

Luca De Nicola

Roberto Minutolo

Links

EU FUNDING

CONTACT